Royal Bank of Canada’s Athira Pharma ATHA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8K | Buy |
27,156
+13,002
| +92% | +$3.83K | ﹤0.01% | 6141 |
|
|
2025
Q1 | $4K | Sell |
14,154
-168,864
| -92% | -$47.7K | ﹤0.01% | 6004 |
|
|
2024
Q4 | $107K | Buy |
183,018
+174,677
| +2,094% | +$102K | ﹤0.01% | 4841 |
|
|
2024
Q3 | $4K | Sell |
8,341
-47,068
| -85% | -$22.6K | ﹤0.01% | 6065 |
|
|
2024
Q2 | $147K | Buy |
55,409
+47,358
| +588% | +$126K | ﹤0.01% | 4606 |
|
|
2024
Q1 | $22K | Sell |
8,051
-27,467
| -77% | -$75.1K | ﹤0.01% | 5423 |
|
|
2023
Q4 | $86K | Buy |
35,518
+33,588
| +1,740% | +$81.3K | ﹤0.01% | 5177 |
|
|
2023
Q3 | $4K | Buy |
1,930
+1,650
| +589% | +$3.42K | ﹤0.01% | 6146 |
|
|
2023
Q2 | $1K | Sell |
280
-1,623
| -85% | -$5.8K | ﹤0.01% | 6495 |
|
|
2023
Q1 | $5K | Sell |
1,903
-3,354
| -64% | -$8.81K | ﹤0.01% | 6161 |
|
|
2022
Q4 | $17K | Buy |
5,257
+1,717
| +49% | +$5.55K | ﹤0.01% | 5890 |
|
|
2022
Q3 | $10K | Buy |
3,540
+3,049
| +621% | +$8.61K | ﹤0.01% | 5920 |
|
|
2022
Q2 | $2K | Sell |
491
-10,126
| -95% | -$41.2K | ﹤0.01% | 6446 |
|
|
2022
Q1 | $143K | Sell |
10,617
-14,845
| -58% | -$200K | ﹤0.01% | 4909 |
|
|
2021
Q4 | $332K | Sell |
25,462
-76,051
| -75% | -$992K | ﹤0.01% | 4336 |
|
|
2021
Q3 | $952K | Sell |
101,513
-53,226
| -34% | -$499K | ﹤0.01% | 3302 |
|
|
2021
Q2 | $1.59M | Buy |
154,739
+22,744
| +17% | +$233K | ﹤0.01% | 2890 |
|
|
2021
Q1 | $2.43M | Buy |
131,995
+54,248
| +70% | +$998K | ﹤0.01% | 2498 |
|
|
2020
Q4 | $2.66M | Buy |
77,747
+50,247
| +183% | +$1.72M | ﹤0.01% | 2287 |
|
|
2020
Q3 | $508K | Buy |
+27,500
| New | +$508K | ﹤0.01% | 3401 |
|